Biomarkers Show Promise for Finding Pancreatic Cancer Risk Early
A research team identified biomarkers that could help distinguish whether cysts on the pancreas will develop into cancer or remain benign.
Read MorePosted by Andy Lundin | Mar 20, 2023 | Pancreatic |
A research team identified biomarkers that could help distinguish whether cysts on the pancreas will develop into cancer or remain benign.
Read MorePosted by Andy Lundin | Mar 7, 2023 | Prostate |
With data showing an increase in advanced prostate cancer cases, doctors at ProCure are urging men over age 55 to get their annual screening.
Read MorePosted by Andy Lundin | Mar 3, 2023 | Urine Analyzers |
Researchers developed a urine sensor that can amplify the light signal of metabolites in urine and in diagnosing cancer in the field.
Read MorePosted by Chris Wolski | Mar 2, 2023 | Prostate, Unknown Origin & Other Cancer Types |
Veracyte CEO Marc Stapley outlines how single-cancer testing is giving pathologists, clinicians, and patients an edge.
Read MorePosted by Andy Lundin | Feb 23, 2023 | Cancer |
Millions of people in the U.S. continued to miss critical cancer screening tests during the second year of the COVID pandemic.
Read More